CPA3

CPA3

Target · Mast cell protease

CPA3 Carboxypeptidase A3 · Mast cell carboxypeptidase A

CPA3 (carboxypeptidase A3) is a zinc metalloprotease of the carboxypeptidase A family, released by mast cells. UniProt names the protein mast cell carboxypeptidase A, and an earlier HGNC name was carboxypeptidase A3 (mast cell). Browse Assay Genie's current range of CPA3 research reagents below, or read on for the biology behind the target.

Secretory vesicle proteinM14 carboxypeptidaseElevated in asthma
417 aa
Protein length
~49 kDa
Molecular weight
3q24
Gene locus
EC 3.4.17.1
Enzyme class
Target information

What is CPA3 (carboxypeptidase A3)?

CPA3 is a member of the carboxypeptidase A family of zinc metalloproteases and belongs to the peptidase M14 family. The enzyme is classified as EC 3.4.17.1. It is made as a preproprotein that is proteolytically processed to a mature protease, which mast cells release. According to the NCBI Gene summary, the secreted enzyme may be involved in degrading endogenous proteins and in inactivating venom-associated peptides.

The human CPA3 gene encodes the protein, and the protein is found in cytoplasmic secretory vesicles. HGNC places it in the M14 carboxypeptidases gene group, alongside related carboxypeptidase A genes such as CPA1, CPA2, CPA4 and CPA5. Mouse and rat each have an ortholog named Cpa3, so the gene can be studied in rodent models. Researchers who work on the CPA3 protein often use it as a mast cell marker, although the source data here do not describe its expression pattern in detail.

The NCBI Gene summary notes that CPA3 expression may be elevated in people with asthma, which links the enzyme to airway inflammation research. The older HGNC name, carboxypeptidase A3 (mast cell), reflects its association with this cell type. Reagents such as a CPA3 antibody or CPA3 ELISA kit are typically used to examine the enzyme in mast cell and allergic disease studies.

Mast cell biology

CPA3 is a protease released by mast cells, so it is relevant to studies of mast cell secretory contents.

Asthma research

CPA3 expression may be elevated in human asthma patients, making it a candidate for studies of airway disease.

Protease and peptide degradation

The mature enzyme may degrade endogenous proteins, so it is relevant to studies of extracellular proteolysis.

Venom peptide inactivation

CPA3 may be involved in inactivating venom-associated peptides, linking it to host defence research.

Background

CPA3 frequently asked questions

What does CPA3 do?

CPA3 is a zinc metalloprotease of the carboxypeptidase A family. After proteolytic processing, the mature enzyme is released by mast cells. It may be involved in degrading endogenous proteins and inactivating venom-associated peptides, according to the NCBI Gene summary.

What other names does CPA3 go by?

The HGNC full name is carboxypeptidase A3, and UniProt calls the protein mast cell carboxypeptidase A. The previous HGNC name was carboxypeptidase A3 (mast cell). No alternative gene symbols are listed. The enzyme is EC 3.4.17.1.

Is CPA3 linked to disease and conserved in other species?

The NCBI Gene summary reports that CPA3 expression may be elevated in human asthma patients. Mouse and rat both have a Cpa3 ortholog, so rodent studies are possible; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other M14 family carboxypeptidase A enzymes with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P15088; product specifications from Assay Genie datasheets.

CPA3 Product listing